Archives
-
Small-Biopsy Dye Models in Surgical Pathology
2026-10-03
The reference study examined whether selected dyes could improve the visibility of very small biopsy fragments during surgical pathology preparation. It found that merbromin, hematoxylin, and Alcian blue improved visual observability, while hematoxylin offered the most favorable balance of visibility, lower toxicity, and limited interference with routine diagnostic assessment.
-
Naloxone Hydrochloride: From Reversal to Translation
2026-10-02
A mechanistic and translational perspective on Naloxone hydrochloride, connecting opioid receptor antagonism with withdrawal biology, neural stem cell research, immune assays, and experimental strategy.
-
SUMO Protease (Ulp): Cleavage Workflow
2026-10-01
SUMO Protease (Ulp), SKU K1103, removes compatible SUMO fusion tags by cleaving immediately downstream of the SUMO C-terminal Gly-Gly motif during recombinant protein purification. It is intended for SUMO-tagged constructs and controlled affinity-purification workflows, not for unrelated tags, general protein degradation, or unvalidated target systems.
-
Lipo3K Transfection Reagent for ccRCC Studies
2026-10-01
Lipo3K Transfection Reagent is a low-toxicity lipid transfection reagent for DNA, siRNA, and mRNA delivery across diverse cell types. Its enhancer-supported plasmid workflow can support gene expression studies that interrogate OTUD3–SLC7A11 regulation and ferroptosis in clear cell renal cell carcinoma.
-
GOB-38 in Elizabethkingia: Activity and Resistance
2026-09-30
The reference study characterizes GOB-38, a metallo-β-lactamase from Elizabethkingia anophelis, using recombinant expression, biochemical profiling, genome analysis, and bacterial co-culture. Its broad substrate range and possible contribution to carbapenem resistance clarify why enzyme-level testing should be combined with genomic and microbiological evidence.
-
MDL 28170: A Mechanism-First Calpain Inhibitor Guide
2026-09-30
MDL 28170 is a cell-permeable calpain inhibitor for connecting protease activity with neuronal injury, apoptosis, and tissue protection. This mechanism-first guide translates recent BDNF/TrkB findings into practical assay decisions while defining the compound’s cross-domain limits.
-
Taltirelin Acetate Research Workflows
2026-09-29
Taltirelin acetate supports integrated workflows spanning dopaminergic motor assays, cellular neuroprotection, itch studies, sleep research, and oral formulation development. Its long-acting TRH-receptor pharmacology is especially useful when sustained pathway modulation must be distinguished from the rapid dopamine fluctuations associated with conventional replacement strategies.
-
Alcian Blue & Nuclear Fast Red in Translation
2026-09-29
A translational framework for using dual staining to connect acid mucin biology, chondrogenic differentiation, and tissue-level evidence without confusing endpoint histochemistry with specimen tracking.
-
Rucaparib Workflows for DNA Damage Research
2026-09-28
Rucaparib (AG-014699) provides a practical way to connect PARP1 inhibition with persistent DNA-break signaling, radiosensitization, and repair-defect biology. This workflow-focused guide covers dosing design, γ-H2AX and p53BP1 assays, transporter-aware interpretation, and how the latest RNA Pol II apoptosis findings can refine mechanistic controls.
-
Lipo3K Transfection Reagent for ASO Assays
2026-09-28
Build a practical workflow for screening nucleic-acid delivery in cancer-cell assays, from plasmid controls to RNA interference readouts. Lipo3K Transfection Reagent offers a low-cytotoxicity option for comparing delivery conditions, while pH-responsive ASO designs require their own structural and functional validation.
-
Designing Clickable PEG-Lipids for RNA Delivery
2026-09-27
DMG-PEG2000-N3 offers a modular azide handle for bioconjugation. This article examines how translational teams can evaluate PEG-lipid chemistry alongside lipid nanoparticle performance and emerging drying strategies—without confusing a useful design option with a clinically validated formulation.
-
Naloxone Hydrochloride: Research Mechanisms
2026-09-26
Naloxone hydrochloride is a potent opioid receptor antagonist for studying opioid-receptor signaling and related biological responses. Product information also describes neural stem cell proliferation modulation through a TET1-dependent, receptor-independent mechanism, which should be tested separately from receptor blockade.
-
Alcian Blue & Nuclear Fast Red Staining Kit: Readout
2026-09-25
The Alcian Blue & Nuclear Fast Red Staining Kit pH2.5 visualizes acidic mucosubstances while preserving nuclear context. This article distinguishes phenotype staining from small-biopsy tissue marking and explains what the evidence does—and does not—support.
-
Alcian Blue & Nuclear Fast Red Staining Kit Guide
2026-09-25
This dual stain helps researchers visualize acidic mucosubstances in tissue sections and assess matrix-rich chondrogenic cultures, with red nuclear contrast to aid morphology review. A small-biopsy study also offers a useful caution: Alcian blue can make tiny samples easier to see during processing, but that tissue-marking use is distinct from validated histochemical staining.
-
Gastric Cancer Assembloids Capture Tumor–Stroma Effects
2026-09-24
Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids that combine tumor organoids with stromal subpopulations from matched tissue. Their findings show that stromal cells can reshape gene-expression profiles and alter drug sensitivity, underscoring the value of tumor–microenvironment models for preclinical and personalized therapy research.